The National Institutes of Health and the best pharmaceuticals for children act

Pediatric Drugs

Volumn 11, Issue 1, 2009, Pages 45-47

  Zajicek, Anne ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Children; Legislation; Pharmacology

Indexed keywords

CHILD HEALTH CARE; CLINICAL PHARMACOLOGY; CONFERENCE PAPER; DRUG FORMULATION; DRUG MECHANISM; DRUG RESEARCH; DRUG USE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; NATIONAL HEALTH ORGANIZATION; PATENT; PRIORITY JOURNAL;

CHILD; CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; DRUG LABELING; GOVERNMENT REGULATION; HUMANS; INFANT; LEGISLATION, DRUG; NATIONAL INSTITUTES OF HEALTH (U.S.); PEDIATRICS; PHARMACEUTICAL PREPARATIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 58149354492     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/0148581-200911010-00015     Document Type: Conference Paper

References (16)

1. Wilson JT. Pediatric pharmacology: who will test the drugs? J Pediatr 1972; 80 (5): 855-7
2. FDAMA. FDA Modernization Act of 1997: CDER-related documents [online]. Available from URL: http://www.fda.gov/cder/fdama/default.htm [Accessed 2008 Dec 8]
3. FDA. Best Pharmaceuticals for Children Act [online]. Available from URL: http://www.fda.gov/opacom/laws/pharmkids/contents.html [Accessed 2008 Dec 9]
4. Eunice Kennedy Shriver National Institute of Child Health and Human Development. Best Pharmaceuticals for Children Act (BPCA) activities at NICHD [online]. Available from URL: http://bpca.nichd.nih.gov [Accessed 2008 Nov 17]
5. GPO. Authenicated US Government information: public law 110-85 - Sep 27, 2007 - 121 stat. 823 [online]. Available from URL: http://frwebgate.access.gpo. gov/cgi-bin/getdoc.cgi?dbname=110_cong_public_laws&docid=f:publ085.110.pdf [Accessed 2008 Dec 8]
6. FedBizOpps.gov. Federal business opportunities [online]. Available from URL: https://www.fbo.gov [Accessed 2008 Dec 5]
7. BPCA. Eunice Kennedy Shriver National Institute of Child Health and Human Development [online]. Available from URL: http://bpca.nichd.nih.gov [Accessed 2008 Dec 5]
8. BPCA. Clinical trials [online]. Available from URL: http://bpca.nichd. nih.gov/ [Accessed 2008 Dec 8]
9. Nelson RM. Challenges in the conduct of emergency research in children: a workshop report. Am J Bioeth 2006; 6 (6): W1-9
10. Witt KL, Shelby MD, Itchon-Ramos N, et al. Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD. J Am Acad Child Adolesc Psychiatry 2008; 47 (12) 1375-83
11. European Medicines Agency (EMEA). Medicines for children: a brighter future for child health [online]. Available from URL: http://www.emea.europa.eu/ htms/human/paediatrics/prioritylist.htm [Accessed 2008 Nov 17]
12. Cordis. Seventh Research Framework Programme [online] Available from URL: http://cordis.europa.eu/fp7/dc/index.cfm?fuseaction=UserSite. CooperationDetailsCallPage& call_id=140 [Accessed 2008 Nov 17]
13. Giacoia GP, Mattison DR. Newborns and drug studies: the NICHD/FDA newborn drug development initiative. Clin Ther 2005; 27 (6): 796-813
14. Kapogiannis BG, Mattison DR. Adolescents in Clinical Trials. Clin Pharmacol Ther 2008 Dec; 84 (6): 655-9
15. Kearns GL, Ritschel WA, Wilson JT, et al. Clinical pharmacology: a discipline called to action for maternal and child health. Clin Pharmacol Ther 2007; 81 (4): 463-8
16. Slikker Jr W, Young JF, Corley RA, et al. Improving predictive modeling in pediatric drug development: pharmacokinetics, pharmacodynamics, and mechanistic modeling. Ann N Y Acad Sci 2005; 1053: 505-18